NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for…
Category: Insights
Worldwide Healthcare Packaging Industry to 2026 – Profiles of Key Players
The “Healthcare Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added…
GT Biopharma Reports First Quarter 2021 Results
GT Biopharma, Inc. (“GT Biopharma” or the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on…
Armata Pharmaceuticals Announces First Quarter Results and Provides General Corporate Update
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific…
Global Yoga Accessories Market- adidas AG, Barefoot Yoga Co., Hugger Mugger Yoga Products LLC Inc., among others to contribute to the market growth
The yoga accessories market is poised to grow by USD 4.99 billion during 2021-2025, progressing at a CAGR of almost…
BioLife Solutions to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining…
Trevi Therapeutics to Report Q1 2021 Financial Results on May 13
Trevi Therapeutics, Inc.(NASDAQ: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of an investigational…
Eiger BioPharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted…
Apollo Medical Holdings, Inc. Reports First Quarter 2021 Results
Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH),…
Nektar Therapeutics Reports First Quarter 2021 Financial Results
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2021. Cash and investments…